BR0112915A - Composição farmacêutica compreendendo metformina e um derivado do tipo 5-fenoxialquil-2,4-tiazolidinadiona - Google Patents

Composição farmacêutica compreendendo metformina e um derivado do tipo 5-fenoxialquil-2,4-tiazolidinadiona

Info

Publication number
BR0112915A
BR0112915A BR0112915-5A BR0112915A BR0112915A BR 0112915 A BR0112915 A BR 0112915A BR 0112915 A BR0112915 A BR 0112915A BR 0112915 A BR0112915 A BR 0112915A
Authority
BR
Brazil
Prior art keywords
phenoxyalkyl
pharmaceutical composition
metformin
thiazolidinedione derivative
type
Prior art date
Application number
BR0112915-5A
Other languages
English (en)
Inventor
Gerard Moinet
Gerard Botton
Didier Mesangeau
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of BR0112915A publication Critical patent/BR0112915A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"COMPOSIçãO FARMACêUTICA COMPREENDENDO METFORMINA E UM DERIVADO DO TIPO 5-FENOXIALQUIL-2,4-TIAZOLIDINADIONA". A presente invenção refere-se a uma composição farmacêutica compreendendo, como ingredientes ativos, metformina optativamente na forma de seus sais farmaceuticamente aceitáveis e uma derivado do tipo de 5-fenoxialquil-2,4-tiazolidinadiona.
BR0112915-5A 2000-08-04 2001-07-24 Composição farmacêutica compreendendo metformina e um derivado do tipo 5-fenoxialquil-2,4-tiazolidinadiona BR0112915A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0010362A FR2812547B1 (fr) 2000-08-04 2000-08-04 Composition pharmaceutique comprenant une association metformine et derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete
PCT/EP2001/008512 WO2002011721A1 (en) 2000-08-04 2001-07-24 Pharmaceutical composition comprising metformin and a 5-phenoxyalkyl-2,4-thiazolidinedione-type derivative

Publications (1)

Publication Number Publication Date
BR0112915A true BR0112915A (pt) 2003-07-08

Family

ID=8853342

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0112915-5A BR0112915A (pt) 2000-08-04 2001-07-24 Composição farmacêutica compreendendo metformina e um derivado do tipo 5-fenoxialquil-2,4-tiazolidinadiona

Country Status (19)

Country Link
US (1) US20040014797A1 (pt)
EP (1) EP1305025A1 (pt)
JP (1) JP2004505915A (pt)
KR (1) KR20030019470A (pt)
CN (1) CN1446090A (pt)
AR (1) AR030309A1 (pt)
AU (1) AU2001282010A1 (pt)
BR (1) BR0112915A (pt)
CA (1) CA2417883A1 (pt)
CZ (1) CZ2003476A3 (pt)
EC (1) ECSP034463A (pt)
FR (1) FR2812547B1 (pt)
HU (1) HUP0303684A2 (pt)
MX (1) MXPA03000975A (pt)
NO (1) NO20030518D0 (pt)
PL (1) PL358791A1 (pt)
RU (1) RU2003105809A (pt)
SK (1) SK2082003A3 (pt)
WO (1) WO2002011721A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003105809A1 (en) 2002-06-17 2003-12-24 Themis Laboratories Private Limited Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
UA80991C2 (en) * 2002-10-07 2007-11-26 Solid preparation containing an insulin resistance improving drug and an active ingredient useful as a remedy for diabetes
WO2008016729A1 (en) * 2006-08-04 2008-02-07 Nastech Pharmaceutical Company Inc. Compositions for intranasal delivery of human insulin and uses thereof
KR100926417B1 (ko) 2007-01-29 2009-11-12 한올제약주식회사 Ｎ,ｎ―디메틸 이미도디카르본이미딕 디아미드의 초산염,그의 제조방법 및 그를 포함하는 약제학적 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2749583B1 (fr) * 1996-06-07 1998-08-21 Lipha Nouveaux derives de thiazolidine -2,4- dione substitues, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
KR20060105005A (ko) * 1997-06-18 2006-10-09 스미스클라인비이참피이엘시이 티아졸리딘디온 및 메트포르민을 사용한 당뇨병의 치료
GB9715295D0 (en) * 1997-07-18 1997-09-24 Smithkline Beecham Plc Novel method of treatment

Also Published As

Publication number Publication date
KR20030019470A (ko) 2003-03-06
NO20030518L (no) 2003-02-03
SK2082003A3 (en) 2003-07-01
JP2004505915A (ja) 2004-02-26
FR2812547B1 (fr) 2002-10-31
CZ2003476A3 (cs) 2003-06-18
EP1305025A1 (en) 2003-05-02
AU2001282010A1 (en) 2002-02-18
FR2812547A1 (fr) 2002-02-08
AR030309A1 (es) 2003-08-20
PL358791A1 (en) 2004-08-23
HUP0303684A2 (hu) 2004-03-01
CA2417883A1 (en) 2002-02-14
RU2003105809A (ru) 2004-08-27
WO2002011721A1 (en) 2002-02-14
ECSP034463A (es) 2003-03-31
MXPA03000975A (es) 2003-06-09
CN1446090A (zh) 2003-10-01
NO20030518D0 (no) 2003-02-03
US20040014797A1 (en) 2004-01-22

Similar Documents

Publication Publication Date Title
BR0307267A (pt) Compostos heterocìclicos, ativos como inibidores de beta-lacta-mases
BR0214403A (pt) Composições farmacêuticas compreendendo metformina e glibenclamida para o tratamento de diabetes melittus tipo ii
BRPI0608178A2 (pt) derivados de aminopirazol, sua fabricação, composição farmacêutica e uso como agentes farmacêuticos
PA8591701A1 (es) Derivados de pirrolopirimidina
MX2007015480A (es) Formulaciones de dosificacion solida de medicamentos narcoticos que tienen adsorcion bucal mejorada.
BRPI0407306A (pt) 1,2,4- triazinas de inibição de hiv
BR0111263A (pt) Derivados de 2-aminocarbonil-9h-purina
RS51569B (en) COMPOSITIONS CONTAINING CRYSTAL TRANS - (+/-) - DELTA-9-TETRAHYDROCANABINOL
MXPA03005464A (es) Agentes antivirales.
ECSP066807A (es) Formulaciones galénicas de compuestos orgánicos
BR9907866A (pt) Composição farmacêutica compreendendo uma combinação de metformina e fibrato, e seu uso para a preparação de medicinas destinadas a reduzir a hiperglicemia
WO2004032909A3 (en) Stabilized pharmaceutical composition containing basic excipients
AR054347A1 (es) Combinaciones terapeuticas para el tratamiento o la prevencion de la depresion
BRPI0408437A (pt) derivados de p-diaminobenzeno substituìdos, composição farmacêutica, e, uso da mesma
BR0212069A (pt) Agentes antidiabéticos orais
BR0210912A (pt) Compostos e composições como inibidores de catepsina
BRPI0408136A (pt) derivados heterocìclicos contendo nitrogênio tendo estirila 2,6-dissubstituìda
UY30847A1 (es) Uso de derivados de mononitrato de dianhidrohexita como agentes para el tratamiento de trastornos intestinales
BR0116060A (pt) Composição farmacêutica de dronedarona para administração parenteral
WO2006031719A3 (en) 1,4-bis-n-oxide-5,8-dihydroxyanthracenedione compounds and the use thereof
BR0112915A (pt) Composição farmacêutica compreendendo metformina e um derivado do tipo 5-fenoxialquil-2,4-tiazolidinadiona
BR0318659A (pt) derivados de prolina usados como ingredientes farmacêuticos ativos no tratamento de tumores
ES2150404T3 (es) Composiciones farmaceuticas de tizoxanida y nitozoxanida.
TW200733981A (en) Hair fitness/body improving agents and hair cosmetics
SE0000303D0 (sv) Novel compounds

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]